OKLO · Oklo Inc.
AI read · Good for OKLO
The AI's read
Oklo announced its Groves Isotope Test Reactor achieved first criticality, a controlled self-sustaining chain reaction at low power. That proves the reactor works and creates a pathway to domestic radioisotope production. The market barely reacted; shares were roughly flat and down 0.25% on the update. Short-term technicals look stretched, RSI 76.93, suggesting some of the immediate upside may be reflected in price. We lean bullish because the milestone meaningfully de-risks the technology and validates the pilot-to-commercial roadmap. Caution warranted: high RSI and limited near-term revenue visibility keep conviction from being extreme.